查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386283

癌症疫苗市场报告：2030 年趋势、预测与竞争分析

Cancer Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

癌症疫苗趋势和预测

预计到 2030 年，全球癌症疫苗市场将达到 155 亿美元，2024 年至 2030 年复合年增长率为 10.5%。该市场的主要驱动因素包括对更有效、侵入性更小的癌症治疗的需求不断增长、人们对癌症疫苗益处的认识不断提高以及政府促进癌症疫苗接种的支持措施。全球癌症疫苗市场前景广阔，医院和政府供应管道充满机会。

癌症疫苗市场洞察

Lucintel 预测，预防癌症发作的预防性疫苗预计将在预测期内达到最高成长。

在这个市场中，由于在医院接受癌症诊断和治疗的人数不断增加，医院在预测期内预计将出现高速成长。

由于癌症患者数量的增加和医疗保健系统的建立，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球癌症疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球癌症疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按疫苗类型分類的全球癌症疫苗市场
    • 预防
    • 治疗性的
  • 按技术分類的全球癌症疫苗市场
    • 重组
    • 全细胞
    • 病毒载体
    • DNA癌症疫苗
  • 按配销通路分類的全球癌症疫苗市场
    • 医院
    • 政府供应商

第四章 2018-2030年区域市场趋势及预测分析

  • 全球癌症疫苗市场按地区划分
  • 北美癌症疫苗市场
  • 欧洲癌症疫苗市场
  • 亚太地区癌症疫苗市场
  • 其他区域癌症疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按疫苗类型分類的全球癌症疫苗市场成长机会
    • 全球癌症疫苗市场成长机会（按技术）
    • 全球癌症疫苗市场成长机会（按配销通路）
    • 全球癌症疫苗市场成长机会（按地区）
  • 全球癌症疫苗市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球癌症疫苗市场的产能
    • 全球癌症疫苗市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • AstraZeneca
  • Bristol-Myers Squibb
简介目录

Cancer Vaccine Trends and Forecast

The future of the global cancer vaccine market looks promising with opportunities in the hospital and government supplier channels. The global cancer vaccine market is expected to reach an estimated $15.5 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising demand for more effective and less invasive cancer treatment, growing awareness of the benefits of cancer vaccines, and supportive government initiatives to promote cancer vaccination.

A more than 150-page report is developed to help in your business decisions.

Cancer Vaccine by Segment

The study includes a forecast for the global cancer vaccine by vaccine type, technology, distribution channel, and region.

Cancer Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Preventive
  • Therapeutic

Cancer Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Recombinant
  • Whole-Cell
  • Viral Vector
  • DNA Cancer Vaccines

Cancer Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Government Suppliers

Cancer Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cancer Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer vaccine companies profiled in this report include-

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • Astrazeneca
  • Bristol-Myers Squibb

Cancer Vaccine Market Insights

Lucintel forecasts that preventive is expected to witness highest growth over the forecast period due to its ability to prevent cancer from developing in the first place.

Within this market, hospital is expected to witness higher growth over the forecast period due to the increasing number of individuals seeking cancer diagnosis and treatment in hospitals.

North America is expected to witness highest growth over the forecast period due to the rising number of cancer patients and presence of well-established healthcare system in the region.

Features of the Global Cancer Vaccine Market

Market Size Estimates: Cancer vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cancer vaccine market size by vaccine type, technology, distribution channel, and region in terms of value ($B).

Regional Analysis: Cancer vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, distribution channels, and regions for the cancer vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cancer vaccine market size?

Answer: The global cancer vaccine market is expected to reach an estimated $15.5 billion by 2030.

Q.2 What is the growth forecast for cancer vaccine market?

Answer: The global cancer vaccine market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cancer vaccine market?

Answer: The major drivers for this market are rising demand for more effective and less invasive cancer treatment, growing awareness of the benefits of cancer vaccines, and supportive government initiatives to promote cancer vaccination.

Q4. What are the major segments for cancer vaccine market?

Answer: The future of the cancer vaccine market looks promising with opportunities in the hospital and government supplier channels.

Q5. Who are the key cancer vaccine market companies?

Answer: Some of the key cancer vaccine companies are as follows:

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • Astrazeneca
  • Bristol-Myers Squibb

Q6. Which cancer vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that preventive is expected to witness highest growth over the forecast period due to its ability to prevent cancer from developing in the first place.

Q7. In cancer vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the rising number of cancer patients and presence of well-established healthcare system in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cancer vaccine market by vaccine type (preventive and therapeutic), technology (recombinant, whole-cell, viral vector, and dna cancer vaccines), distribution channel (hospitals and government suppliers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cancer Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cancer Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cancer Vaccine Market by Vaccine Type
    • 3.3.1: Preventive
    • 3.3.2: Therapeutic
  • 3.4: Global Cancer Vaccine Market by Technology
    • 3.4.1: Recombinant
    • 3.4.2: Whole-Cell
    • 3.4.3: Viral Vector
    • 3.4.4: DNA Cancer Vaccines
  • 3.5: Global Cancer Vaccine Market by Distribution Channel
    • 3.5.1: Hospitals
    • 3.5.2: Government Suppliers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cancer Vaccine Market by Region
  • 4.2: North American Cancer Vaccine Market
    • 4.2.2: North American Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.3: European Cancer Vaccine Market
    • 4.3.1: European Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.3.2: European Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.4: APAC Cancer Vaccine Market
    • 4.4.1: APAC Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.4.2: APAC Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.5: ROW Cancer Vaccine Market
    • 4.5.1: ROW Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.5.2: ROW Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cancer Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Cancer Vaccine Market by Technology
    • 6.1.3: Growth Opportunities for the Global Cancer Vaccine Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Cancer Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cancer Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cancer Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: GSK
  • 7.3: Dendreon Pharmaceuticals
  • 7.4: Dynavax Technologies
  • 7.5: Ferring
  • 7.6: Amgen
  • 7.7: Moderna
  • 7.8: Sanofi
  • 7.9: AstraZeneca
  • 7.10: Bristol-Myers Squibb